Breaking News Instant updates and real-time market news.

WILC

G. Willi-Food

$10.18 /

+ (+0.00%)

11:43
07/18/19
07/18
11:43
07/18/19
11:43

G. Willi-Food announces CFO Amir Kaplan resigns

G. Willi-Food International announced that Amir Kaplan submitted a letter of resignation as CFO of the company, effective as of September 1. In addition, the company announced the appointment of Mr. Yitschak Barabi, the current controller and deputy CFO of the Company, as Finance Manager of the company, effective as of September 1. Mr. Barabi will serve as the principal financial officer of the company.

TODAY'S FREE FLY STORIES

Earnings
Disney reports Q3 EPS ex-items 8c, consensus (64c) » 16:06
08/04/20
08/04
16:06
08/04/20
16:06
DIS

Disney

$117.36 /

+0.98 (+0.84%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$117.36 /

+0.98 (+0.84%)

DIS Disney
$117.36 /

+0.98 (+0.84%)

07/24/20 JPMorgan
Disney delay of 'Mulan' not a surprise, says JPMorgan
07/16/20
Fly Intel: Top five analyst downgrades
07/16/20 Cowen
Disney downgraded to Market Perform from Outperform at Cowen
07/13/20
Fly Intel: Top five analyst initiations
DIS Disney
$117.36 /

+0.98 (+0.84%)

DIS Disney
$117.36 /

+0.98 (+0.84%)

DIS Disney
$117.36 /

+0.98 (+0.84%)

DIS Disney
$117.36 /

+0.98 (+0.84%)

Earnings
Triumph Group sees FY21 revenue $1.8B-$1.9B, consensus $1.97B  16:06
08/04/20
08/04
16:06
08/04/20
16:06
TGI

Triumph Group

$6.74 /

-0.125 (-1.82%)

 
ShowHide Related Items >><<
TGI Triumph Group
$6.74 /

-0.125 (-1.82%)

TGI Triumph Group
$6.74 /

-0.125 (-1.82%)

07/15/20 SunTrust
SunTrust downgrades select commercial aviation supply stocks
07/15/20 SunTrust
Triumph Group downgraded to Sell from Hold at SunTrust
03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
TGI Triumph Group
$6.74 /

-0.125 (-1.82%)

TGI Triumph Group
$6.74 /

-0.125 (-1.82%)

Earnings
Twilio reports Q2 adjusted EPS 9c, consensus (9c) » 16:06
08/04/20
08/04
16:06
08/04/20
16:06
TWLO

Twilio

$284.40 /

-1.98 (-0.69%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWLO Twilio
$284.40 /

-1.98 (-0.69%)

TWLO Twilio
$284.40 /

-1.98 (-0.69%)

07/27/20 Rosenblatt
Vonage initiated with a Neutral at Rosenblatt
07/24/20 Wolfe Research
Twilio initiated with an Outperform at Wolfe Research
07/20/20 Morgan Stanley
Twilio price target raised to $240 from $160 at Morgan Stanley
07/17/20 Cowen
Twilio price target raised to $260 from $230 at Cowen
TWLO Twilio
$284.40 /

-1.98 (-0.69%)

TWLO Twilio
$284.40 /

-1.98 (-0.69%)

TWLO Twilio
$284.40 /

-1.98 (-0.69%)

TWLO Twilio
$284.40 /

-1.98 (-0.69%)

Earnings
CDK Global reports Q4 adjusted EPS 67c, consensus 50c » 16:06
08/04/20
08/04
16:06
08/04/20
16:06
CDK

CDK Global

$46.79 /

+0.64 (+1.39%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDK CDK Global
$46.79 /

+0.64 (+1.39%)

CDK CDK Global
$46.79 /

+0.64 (+1.39%)

07/15/20 Wells Fargo
CDK Global price target raised to $50 from $45 at Wells Fargo
06/08/20 Morgan Stanley
CDK Global upgraded to Overweight from Equal Weight at Morgan Stanley
04/08/20 Wells Fargo
CDK Global price target lowered to $45 from $65 at Wells Fargo
04/02/20 Barrington
CDK Global target range lowered to $50-$60 from $60-$70 at Barrington
CDK CDK Global
$46.79 /

+0.64 (+1.39%)

Earnings
Kratos Defense sees Q3 revenue $195M-$205M, consensus $197.35M  16:06
08/04/20
08/04
16:06
08/04/20
16:06
KTOS

Kratos Defense

$18.49 /

+0.2 (+1.09%)

 
ShowHide Related Items >><<
KTOS Kratos Defense
$18.49 /

+0.2 (+1.09%)

KTOS Kratos Defense
$18.49 /

+0.2 (+1.09%)

08/03/20 Canaccord
Kratos Defense second half catalysts should support shares. says Canaccord
07/24/20 Benchmark
Kratos Defense price target raised to $26 from $19 at Benchmark
07/20/20 Baird
Kratos Defense designated a Fresh Pick at Baird
04/06/20 Canaccord
Kratos Defense acquisition provides long-term opportunity, says Canaccord
KTOS Kratos Defense
$18.49 /

+0.2 (+1.09%)

  • 19
    Jun
KTOS Kratos Defense
$18.49 /

+0.2 (+1.09%)

KTOS Kratos Defense
$18.49 /

+0.2 (+1.09%)

Earnings
Rigel Pharmaceuticals reports Q2 EPS (10c), consensus (13c) » 16:05
08/04/20
08/04
16:05
08/04/20
16:05
RIGL

Rigel Pharmaceuticals

$2.45 /

+0.025 (+1.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$2.45 /

+0.025 (+1.03%)

RIGL Rigel Pharmaceuticals
$2.45 /

+0.025 (+1.03%)

07/13/20 Cantor Fitzgerald
Cantor says research supports studying Rigel's fostamatinib in treating COVID-19
07/13/20 Citi
Study points to possible role for Rigel in treating COVID injury, says Citi
02/27/20 Piper Sandler
Piper Sandler continues to like Rigel Pharmaceuticals setup
01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
RIGL Rigel Pharmaceuticals
$2.45 /

+0.025 (+1.03%)

RIGL Rigel Pharmaceuticals
$2.45 /

+0.025 (+1.03%)

RIGL Rigel Pharmaceuticals
$2.45 /

+0.025 (+1.03%)

Earnings
Triumph Group reports Q2 EPS (19c), consensus (22c) » 16:05
08/04/20
08/04
16:05
08/04/20
16:05
TGI

Triumph Group

$6.77 /

-0.095 (-1.38%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGI Triumph Group
$6.77 /

-0.095 (-1.38%)

TGI Triumph Group
$6.77 /

-0.095 (-1.38%)

07/15/20 SunTrust
SunTrust downgrades select commercial aviation supply stocks
07/15/20 SunTrust
Triumph Group downgraded to Sell from Hold at SunTrust
03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
TGI Triumph Group
$6.77 /

-0.095 (-1.38%)

TGI Triumph Group
$6.77 /

-0.095 (-1.38%)

Earnings
Xencor reports Q2 EPS (61c), consensus (50c) » 16:04
08/04/20
08/04
16:04
08/04/20
16:04
XNCR

Xencor

$30.85 /

-0.97 (-3.05%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XNCR Xencor
$30.85 /

-0.97 (-3.05%)

XNCR Xencor
$30.85 /

-0.97 (-3.05%)

07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
06/22/20 Piper Sandler
Xencor's '2+1' biospecific antibodies ideal for solid tumors, says Piper Sandler
05/13/20 Piper Sandler
Xencor's XmAb20717 shows first-ever clinical benefit, says Piper Sandler
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
XNCR Xencor
$30.85 /

-0.97 (-3.05%)

XNCR Xencor
$30.85 /

-0.97 (-3.05%)

Earnings
Kratos Defense reports Q2 EPS 8c, consensus 6c » 16:04
08/04/20
08/04
16:04
08/04/20
16:04
KTOS

Kratos Defense

$18.52 /

+0.23 (+1.26%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$18.52 /

+0.23 (+1.26%)

KTOS Kratos Defense
$18.52 /

+0.23 (+1.26%)

08/03/20 Canaccord
Kratos Defense second half catalysts should support shares. says Canaccord
07/24/20 Benchmark
Kratos Defense price target raised to $26 from $19 at Benchmark
07/20/20 Baird
Kratos Defense designated a Fresh Pick at Baird
04/06/20 Canaccord
Kratos Defense acquisition provides long-term opportunity, says Canaccord
KTOS Kratos Defense
$18.52 /

+0.23 (+1.26%)

  • 19
    Jun
KTOS Kratos Defense
$18.52 /

+0.23 (+1.26%)

KTOS Kratos Defense
$18.52 /

+0.23 (+1.26%)

Earnings
Cerus backs FY20 product revenue view $89M-$93M » 16:04
08/04/20
08/04
16:04
08/04/20
16:04
CERS

Cerus

$7.45 /

+0.04 (+0.54%)

The Company expects 2020…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERS Cerus
$7.45 /

+0.04 (+0.54%)

CERS Cerus
$7.45 /

+0.04 (+0.54%)

06/16/20 Cantor Fitzgerald
Cerus assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
Cerus assumed with an Overweight at Cantor Fitzgerald
05/26/20 Stifel
Cerus price target raised to $8 from $7 at Stifel
02/26/20 BTIG
Cerus initiated with a Buy at BTIG
CERS Cerus
$7.45 /

+0.04 (+0.54%)

  • 29
    Jan
CERS Cerus
$7.45 /

+0.04 (+0.54%)

Earnings
Red Rock Resorts reports Q2 EPS ($1.01), consensus ($1.07) » 16:03
08/04/20
08/04
16:03
08/04/20
16:03
RRR

Red Rock Resorts

$12.23 /

+0.56 (+4.80%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RRR Red Rock Resorts
$12.23 /

+0.56 (+4.80%)

RRR Red Rock Resorts
$12.23 /

+0.56 (+4.80%)

05/20/20 JPMorgan
Red Rock Resorts price target lowered to $13 from $30 at JPMorgan
05/20/20 Deutsche Bank
Red Rock Resorts price target lowered to $14 from $31 at Deutsche Bank
05/20/20 Stifel
Red Rock Resorts price target lowered to $13 from $28 at Stifel
05/20/20 Nomura Instinet
Red Rock Resorts price target lowered to $14 from $30 at Nomura Instinet
RRR Red Rock Resorts
$12.23 /

+0.56 (+4.80%)

RRR Red Rock Resorts
$12.23 /

+0.56 (+4.80%)

RRR Red Rock Resorts
$12.23 /

+0.56 (+4.80%)

Earnings
WW reports Q2 EPS 67c, consensus 70c » 16:03
08/04/20
08/04
16:03
08/04/20
16:03
WW

WW

$26.46 /

-0.41 (-1.53%)

Reports Q2 revenue $334M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WW WW
$26.46 /

-0.41 (-1.53%)

WW WW
$26.46 /

-0.41 (-1.53%)

06/17/20 Guggenheim
WW price target raised to $34 from $28 at Guggenheim
06/12/20 Guggenheim
WW initiated with a Buy at Guggenheim
05/13/20
Fly Intel: Top five analyst initiations
05/12/20 Jefferies
WW initiated with a Buy at Jefferies
WW WW
$26.46 /

-0.41 (-1.53%)

WW WW
$26.46 /

-0.41 (-1.53%)

WW WW
$26.46 /

-0.41 (-1.53%)

Earnings
Cerus reports Q2 EPS (13c), consensus (11c) » 16:03
08/04/20
08/04
16:03
08/04/20
16:03
CERS

Cerus

$7.45 /

+0.04 (+0.54%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERS Cerus
$7.45 /

+0.04 (+0.54%)

CERS Cerus
$7.45 /

+0.04 (+0.54%)

06/16/20 Cantor Fitzgerald
Cerus assumed with an Overweight at Cantor Fitzgerald
06/15/20 Cantor Fitzgerald
Cerus assumed with an Overweight at Cantor Fitzgerald
05/26/20 Stifel
Cerus price target raised to $8 from $7 at Stifel
02/26/20 BTIG
Cerus initiated with a Buy at BTIG
CERS Cerus
$7.45 /

+0.04 (+0.54%)

  • 29
    Jan
CERS Cerus
$7.45 /

+0.04 (+0.54%)

Earnings
Nikola reports Q2 EPS (33c), consensus (13c) » 16:03
08/04/20
08/04
16:03
08/04/20
16:03
NKLA

Nikola

$38.98 /

+2.51 (+6.88%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola
$38.98 /

+2.51 (+6.88%)

NKLA Nikola
$38.98 /

+2.51 (+6.88%)

08/03/20 Deutsche Bank
Nikola named short-term buy ahead of results at Deutsche Bank
07/20/20 Deutsche Bank
Nikola filing may bring 'large technical selling pressure,' says Deutsche Bank
07/16/20
Fly Intel: Top five analyst initiations
07/16/20 Deutsche Bank
Nikola initiated with a Hold at Deutsche Bank
NKLA Nikola
$38.98 /

+2.51 (+6.88%)

NKLA Nikola
$38.98 /

+2.51 (+6.88%)

NKLA Nikola
$38.98 /

+2.51 (+6.88%)

NKLA Nikola
$38.98 /

+2.51 (+6.88%)

Earnings
Acorda Therapeutics sees 2020 Ampyra net revenue $85M-$110M » 16:03
08/04/20
08/04
16:03
08/04/20
16:03
ACOR

Acorda Therapeutics

$0.66 /

+0.0258 (+4.07%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACOR Acorda Therapeutics
$0.66 /

+0.0258 (+4.07%)

ACOR Acorda Therapeutics
$0.66 /

+0.0258 (+4.07%)

10/24/19 JPMorgan
JPMorgan downgrades Acorda to Underweight on disappointing Inbrija launch
10/24/19 JPMorgan
Acorda Therapeutics downgraded to Underweight from Neutral at JPMorgan
09/30/19 BofA/Merrill
Adamas Pharmaceuticals downgraded to Underperform from Neutral at BofA/Merrill
08/14/19 H.C. Wainwright
Acorda Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
ACOR Acorda Therapeutics
$0.66 /

+0.0258 (+4.07%)

Earnings
Vapotherm sees Q3 revenue $24M-$28M, consensus $18.65M » 16:03
08/04/20
08/04
16:03
08/04/20
16:03
VAPO

Vapotherm

$53.59 /

+0.66 (+1.25%)

The company added,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

  • 07
    May
VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

Earnings
Avalara sees FY20 revenue $465M-$470M, consensus $460.24M » 16:02
08/04/20
08/04
16:02
08/04/20
16:02
AVLR

Avalara

$137.22 /

-1.645 (-1.18%)

Sees FY20 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVLR Avalara
$137.22 /

-1.645 (-1.18%)

AVLR Avalara
$137.22 /

-1.645 (-1.18%)

06/24/20 Needham
Avalara price target raised to $150 from $116 at Needham
06/24/20 Canaccord
Avalara price target raised to $150 from $115 at Canaccord
06/24/20 Goldman Sachs
Avalara price target raised to $154 from $117 at Goldman Sachs
06/24/20 Mizuho
Avalara price target raised to $150 from $120 at Mizuho
AVLR Avalara
$137.22 /

-1.645 (-1.18%)

  • 22
    Aug
Earnings
Vapotherm reports Q2 EPS (35c), consensus (39c) » 16:02
08/04/20
08/04
16:02
08/04/20
16:02
VAPO

Vapotherm

$53.59 /

+0.66 (+1.25%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

  • 07
    May
VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

VAPO Vapotherm
$53.59 /

+0.66 (+1.25%)

Earnings
Avalara sees Q3 revenue $115M-$117M, consensus $115.15M » 16:02
08/04/20
08/04
16:02
08/04/20
16:02
AVLR

Avalara

$137.19 /

-1.67 (-1.20%)

Sees Q3 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVLR Avalara
$137.19 /

-1.67 (-1.20%)

AVLR Avalara
$137.19 /

-1.67 (-1.20%)

06/24/20 Needham
Avalara price target raised to $150 from $116 at Needham
06/24/20 Canaccord
Avalara price target raised to $150 from $115 at Canaccord
06/24/20 Goldman Sachs
Avalara price target raised to $154 from $117 at Goldman Sachs
06/24/20 Mizuho
Avalara price target raised to $150 from $120 at Mizuho
AVLR Avalara
$137.19 /

-1.67 (-1.20%)

  • 22
    Aug
Earnings
Verisk Analytics reports Q2 EPS $1.08, consensus $1.19 » 16:02
08/04/20
08/04
16:02
08/04/20
16:02
VRSK

Verisk Analytics

$186.84 /

-0.3 (-0.16%)

Reports Q2 revenue $679M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRSK Verisk Analytics
$186.84 /

-0.3 (-0.16%)

VRSK Verisk Analytics
$186.84 /

-0.3 (-0.16%)

05/07/20 Wells Fargo
Verisk Analytics price target raised to $190 from $175 at Wells Fargo
04/01/20 Baird
Verisk Analytics a good defensive long term core holding, says Baird
03/30/20 RBC Capital
Verisk Analytics initiated with a Sector Perform at RBC Capital
01/22/20 Baird
Verisk Analytics price target raised to $184 from $165 at Baird
VRSK Verisk Analytics
$186.84 /

-0.3 (-0.16%)

Hot Stocks
Cloudera appoints Sarah Shin as chief diversity officer » 16:02
08/04/20
08/04
16:02
08/04/20
16:02
CLDR

Cloudera

$11.53 /

+0.02 (+0.17%)

Cloudera announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDR Cloudera
$11.53 /

+0.02 (+0.17%)

CLDR Cloudera
$11.53 /

+0.02 (+0.17%)

06/10/20 Morgan Stanley
Morgan Stanley says Cloudera could be valued at $14.50 using typical PE multiple
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
06/09/20 Northland
Northland downgrades Cloudera to Market Perform as coverage transferred
06/03/20
Fly Intel: Top five analyst upgrades
CLDR Cloudera
$11.53 /

+0.02 (+0.17%)

CLDR Cloudera
$11.53 /

+0.02 (+0.17%)

CLDR Cloudera
$11.53 /

+0.02 (+0.17%)

CLDR Cloudera
$11.53 /

+0.02 (+0.17%)

Earnings
Avalara reports Q2 adjusted EPS 4c, consensus (10c) » 16:01
08/04/20
08/04
16:01
08/04/20
16:01
AVLR

Avalara

$137.19 /

-1.67 (-1.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVLR Avalara
$137.19 /

-1.67 (-1.20%)

AVLR Avalara
$137.19 /

-1.67 (-1.20%)

06/24/20 Needham
Avalara price target raised to $150 from $116 at Needham
06/24/20 Canaccord
Avalara price target raised to $150 from $115 at Canaccord
06/24/20 Goldman Sachs
Avalara price target raised to $154 from $117 at Goldman Sachs
06/24/20 Mizuho
Avalara price target raised to $150 from $120 at Mizuho
AVLR Avalara
$137.19 /

-1.67 (-1.20%)

  • 22
    Aug
Earnings
Acorda Therapeutics reports Q2 EPS (37c), consensus (48c) » 16:01
08/04/20
08/04
16:01
08/04/20
16:01
ACOR

Acorda Therapeutics

$0.67 /

+0.0335 (+5.28%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACOR Acorda Therapeutics
$0.67 /

+0.0335 (+5.28%)

ACOR Acorda Therapeutics
$0.67 /

+0.0335 (+5.28%)

10/24/19 JPMorgan
JPMorgan downgrades Acorda to Underweight on disappointing Inbrija launch
10/24/19 JPMorgan
Acorda Therapeutics downgraded to Underweight from Neutral at JPMorgan
09/30/19 BofA/Merrill
Adamas Pharmaceuticals downgraded to Underperform from Neutral at BofA/Merrill
08/14/19 H.C. Wainwright
Acorda Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
ACOR Acorda Therapeutics
$0.67 /

+0.0335 (+5.28%)

Upgrade
Craig-Hallum upgrades Bio-Techne on 'powerful, long-term trend' » 15:52
08/04/20
08/04
15:52
08/04/20
15:52
TECH

Bio-Techne

$271.48 /

-7.67 (-2.75%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TECH Bio-Techne
$271.48 /

-7.67 (-2.75%)

TECH Bio-Techne
$271.48 /

-7.67 (-2.75%)

15:49 Today Craig-Hallum
Bio-Techne upgraded to Buy from Hold at Craig-Hallum
07/15/20 Stephens
Bio-Techne downgraded to Equal Weight from Overweight at Stephens
05/27/20 Stifel
Bio-Techne downgraded to Hold from Buy at Stifel
05/14/20 Benchmark
Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy
TECH Bio-Techne
$271.48 /

-7.67 (-2.75%)

Upgrade
Bio-Techne upgraded to Buy from Hold at Craig-Hallum » 15:49
08/04/20
08/04
15:49
08/04/20
15:49
TECH

Bio-Techne

$271.04 /

-8.11 (-2.91%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TECH Bio-Techne
$271.04 /

-8.11 (-2.91%)

TECH Bio-Techne
$271.04 /

-8.11 (-2.91%)

07/15/20 Stephens
Bio-Techne downgraded to Equal Weight from Overweight at Stephens
05/27/20 Stifel
Bio-Techne downgraded to Hold from Buy at Stifel
05/14/20 Benchmark
Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy
05/14/20 Benchmark
Bio-Techne initiated with a Buy at Benchmark
TECH Bio-Techne
$271.04 /

-8.11 (-2.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.